George Demetri, Director at Blueprint Medicines Corp (BPMC), sold 568 shares at $85.00 ($48K) on 2020-01-10, disclosed to the SEC on 2020-01-14.
Scheduled sale ($48k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BPMC | SELL | 2021-01-06 | $170K | — | Filing → |
| BPMC | SELL | 2020-09-24 | $145K | — | Filing → |
| BPMC | SELL | 2020-01-09 | $275K | — | Filing → |